The company is dedicated to designing and producing innovative medicines that have no equal in their class. Their primary focus is on the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a critical mediator in cytokine signaling pathways that are associated with various immune-mediated inflammatory conditions. Sudo Biosciences is committed to transforming the lives of patients by creating best-in-class drugs that target these pathways, providing hope for people suffering from these debilitating diseases.